Cargando…

Prevalence and treatment of patients with eating disorders: Data of a german health insurance

INTRODUCTION: Few studies have examined the course of eating disorders and the respective treatments based on insurance data, even though they provide representative information. OBJECTIVES: To assess the epidemiology, treatments, duration of illness, costs of treatment in a data set of a public hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrmann, K., Kaluscha, R., Liebert, A., Wietersheim, J. Von
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470461/
http://dx.doi.org/10.1192/j.eurpsy.2021.324
_version_ 1784788849712431104
author Herrmann, K.
Kaluscha, R.
Liebert, A.
Wietersheim, J. Von
author_facet Herrmann, K.
Kaluscha, R.
Liebert, A.
Wietersheim, J. Von
author_sort Herrmann, K.
collection PubMed
description INTRODUCTION: Few studies have examined the course of eating disorders and the respective treatments based on insurance data, even though they provide representative information. OBJECTIVES: To assess the epidemiology, treatments, duration of illness, costs of treatment in a data set of a public health insurance. METHODS: Data provided by a German health insurance (data from 4.2 million members from 2005-2010). A matched control group based on age and gender without an eating disorder diagnosis was used for comparisons. RESULTS: 2.734 cases with the diagnoses of an eating disorder (anorexia nervosa AN, bulimia nervosa BN or combination ANBN) were identified. More than 92% of the patients were female. The relative risk for personality disorders, depressive disorders, alcohol abuse and obsessive-compulsive disorders was highly increased. Most of the patients with BN (53.04%) or AN (41.57%) were treated in out-patient care, and many were only treated for three months, whereas most of the patients with ANBN were treated for a longer time. 3-19% with BN, AN or ANBN were treated only in in-patient care. The in-patient costs of treatment for the year of the diagnosis were 5471.15€ for BN, 9080.26€ for AN, 10809.16€ for ANBN and 339.37€ for the control group. CONCLUSIONS: Our findings suggest that patients with ANBN diagnosis have a severe and longer course of treatment. Furthermore, contrary to national guidelines for eating disorders, there is a considerable proportion of patients with BN or AN that are treated only in in-patient care. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9470461
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94704612022-09-29 Prevalence and treatment of patients with eating disorders: Data of a german health insurance Herrmann, K. Kaluscha, R. Liebert, A. Wietersheim, J. Von Eur Psychiatry Abstract INTRODUCTION: Few studies have examined the course of eating disorders and the respective treatments based on insurance data, even though they provide representative information. OBJECTIVES: To assess the epidemiology, treatments, duration of illness, costs of treatment in a data set of a public health insurance. METHODS: Data provided by a German health insurance (data from 4.2 million members from 2005-2010). A matched control group based on age and gender without an eating disorder diagnosis was used for comparisons. RESULTS: 2.734 cases with the diagnoses of an eating disorder (anorexia nervosa AN, bulimia nervosa BN or combination ANBN) were identified. More than 92% of the patients were female. The relative risk for personality disorders, depressive disorders, alcohol abuse and obsessive-compulsive disorders was highly increased. Most of the patients with BN (53.04%) or AN (41.57%) were treated in out-patient care, and many were only treated for three months, whereas most of the patients with ANBN were treated for a longer time. 3-19% with BN, AN or ANBN were treated only in in-patient care. The in-patient costs of treatment for the year of the diagnosis were 5471.15€ for BN, 9080.26€ for AN, 10809.16€ for ANBN and 339.37€ for the control group. CONCLUSIONS: Our findings suggest that patients with ANBN diagnosis have a severe and longer course of treatment. Furthermore, contrary to national guidelines for eating disorders, there is a considerable proportion of patients with BN or AN that are treated only in in-patient care. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9470461/ http://dx.doi.org/10.1192/j.eurpsy.2021.324 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Herrmann, K.
Kaluscha, R.
Liebert, A.
Wietersheim, J. Von
Prevalence and treatment of patients with eating disorders: Data of a german health insurance
title Prevalence and treatment of patients with eating disorders: Data of a german health insurance
title_full Prevalence and treatment of patients with eating disorders: Data of a german health insurance
title_fullStr Prevalence and treatment of patients with eating disorders: Data of a german health insurance
title_full_unstemmed Prevalence and treatment of patients with eating disorders: Data of a german health insurance
title_short Prevalence and treatment of patients with eating disorders: Data of a german health insurance
title_sort prevalence and treatment of patients with eating disorders: data of a german health insurance
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470461/
http://dx.doi.org/10.1192/j.eurpsy.2021.324
work_keys_str_mv AT herrmannk prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance
AT kaluschar prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance
AT lieberta prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance
AT wietersheimjvon prevalenceandtreatmentofpatientswitheatingdisordersdataofagermanhealthinsurance